Incentive Spirometer and Inspiratory Muscle Trainer

A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05201742

Enrollment

Registered

2022-01-21

Start date

2017-02-06

Completion date

2018-05-10

Last updated

2022-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson disease, Incentive spirometer, Inspiratory muscle trainer, Pulmonary functions

Brief summary

Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.

Detailed description

The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.

Interventions

OTHERInspiratory muscle training

Threshold inspiratory muscle training was performed for 6 weeks with device.

OTHERIncentive Spirometry

Incentive spirometry was performed for 6 weeks with device.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

65 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Patients diagnosed as having Parkinsonism Disease by the Neuro physician. * Duration of Parkinson's Disease ≥ 5 years. * Patients with the age of 65 to 80 years. * Hoen and Yahr classification within 1 to 3. * Both males and females were included. * Patients who were able to comprehend the commands. * Patients who were willing to participate.

Exclusion criteria

* Patients having any cardiovascular and pulmonary disorders. * History of smoking currently or in the past. * Psychological Impairment. * Insufficient verbal/intellectual understanding. * Patients with unstable vital parameters. * Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.

Design outcomes

Primary

Measure	Time frame	Description
Maximum inspiratory pressure (MIP)	6 weeks	Maximum inspiratory pressure was measured.
6-minute walk distance (6 MWD)	6 weeks	Distance walked by the patients in 6 minutes was measured.
Forced vital capacity (FVC)	6 weeks	Forced vital capacity was measured.
Forced expiratory volume in 1 second (FEV1)	6 weeks	Forced expiratory volume in 1 second was measured
Peak Expiratory Flow Rate (PEFR)	6 weeks	Peak Expiratory Flow Rate was measured

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026